The thyroid nodule: TSH first, then ultrasound
- Diagnostic approach
Thyroid lumps are very common and almost all are harmless. A short, ordered workup finds the few cancers without putting a needle into everyone.
See it in 3D: Thyroid gland
What it is
A thyroid nodule is a discrete lesion distinct from the surrounding gland. About one adult in twenty has a palpable nodule, and ultrasound finds nodules in a large share of adults, more often in women and with age. Only a small minority are cancers. The workup has a fixed order: TSH, then ultrasound, then fine-needle aspiration (FNA) only for nodules whose size and ultrasound pattern justify it, with cytology reported in the six Bethesda categories. Ultrasound features are added up into a risk score (TI-RADS, the Thyroid Imaging Reporting and Data System, and similar systems): points for a solid composition, hypoechoic or very hypoechoic echogenicity, a taller-than-wide shape, irregular or lobulated margins or extension outside the gland, and echogenic foci such as microcalcifications. The total places the nodule in a category from benign to highly suspicious, and each category has its own size threshold for FNA. When cytology is indeterminate (Bethesda III or IV), molecular testing of the aspirate (gene expression or mutation and fusion panels, such as BRAF, RAS and RET) can make cancer more or less likely and spare some patients a diagnostic lobectomy.
What to know
- Red flags in the history: childhood neck radiation, family history of thyroid cancer or MEN2, rapid growth, hoarseness, a hard fixed nodule, enlarged neck nodes.
- A low TSH suggests a hot nodule: confirm with scintigraphy; a hot nodule is not biopsied.
- Suspicious ultrasound features: solid, hypoechoic, irregular or infiltrative margins, taller than wide, microcalcifications, extension outside the thyroid, abnormal lymph nodes.
- Reassuring patterns: a purely cystic nodule and a spongiform nodule.
- The size at which FNA is advised depends on the pattern: suspicious nodules from about 1 cm, low-suspicion ones only when larger.
- FNA cannot tell a follicular adenoma from a follicular carcinoma: that needs the whole capsule examined for invasion.
- Calcitonin is the marker of medullary carcinoma and is measured when MEN2 or medullary cancer is suspected.
- TI-RADS adds points for composition, echogenicity, shape, margins and echogenic foci; in the American College of Radiology version, FNA is advised from about 1 cm in the highest category (TR5), 1.5 cm in TR4 and 2.5 cm in TR3, and not at all in TR1 and TR2.
- The risk of cancer climbs across Bethesda: low in II (benign), roughly a fifth to a third in III and IV, most in V and nearly all in VI.
- Molecular testing in Bethesda III or IV: a negative result with a high negative predictive value supports ultrasound follow-up instead of surgery; BRAF V600E or a RET or other gene fusion points strongly to cancer; RAS variants suggest a follicular-pattern neoplasm that may still be benign.
Step-by-step approach
- History and examination, looking for red flags and neck nodes.
- Measure TSH.
- TSH low: thyroid scintigraphy; a hot nodule is treated as hyperthyroidism, without biopsy.
- TSH normal or high: ultrasound of the thyroid and the neck lymph nodes., with the features scored into a TI-RADS category
- FNA under ultrasound guidance when size and pattern meet the criteria, and for suspicious nodes.
- Act on the Bethesda category (for III and IV, repeat FNA or molecular testing before deciding on lobectomy); follow benign nodules with ultrasound.
Bethesda categories for thyroid cytology
| Category | Meaning | Usual next step |
|---|---|---|
| I. Non-diagnostic | Too few cells to judge | Repeat FNA under ultrasound |
| II. Benign | Colloid or hyperplastic nodule, thyroiditis | Ultrasound follow-up |
| III. Atypia of undetermined significance | Some atypical cells | Repeat FNA, molecular testing or lobectomy |
| IV. Follicular neoplasm | Follicular pattern; adenoma or carcinoma cannot be separated | Molecular testing or diagnostic lobectomy |
| V. Suspicious for malignancy | Features suggest cancer | Surgery |
| VI. Malignant | Cancer, usually papillary | Surgery, extent planned with the team |
Keys to the differential
- Nodules in children carry a higher risk of cancer and are assessed by a specialist team.
- In pregnancy, FNA can be done safely; surgery for a well-differentiated cancer is often deferred until after delivery.
- A nodule found incidentally on a PET scan with high uptake has a higher cancer risk and needs evaluation.
Next step / Initial management
- TSH for every nodule; ultrasound of the thyroid and neck.
- FNA only when size and pattern justify it; scintigraphy only when TSH is low.
- Benign nodules: repeat ultrasound at intervals; treat only if growing or compressing.
- Refer to endocrinology or head and neck surgery for Bethesda III–VI, suspicious nodes, compressive symptoms, red flags or a child.
Common traps
- Every thyroid nodule needs scintigraphy: it only helps when TSH is low.
- A hot nodule should be biopsied: its cytology often looks worrying though it is benign.
- FNA can diagnose follicular carcinoma: follicular carcinoma is defined by invasion of the capsule or vessels, which is seen only in the removed nodule.
- CT or MRI is the best way to judge a nodule: ultrasound is the test.
- The nodule ultrasound only needs to look at the nodule: abnormal neck nodes change the plan, so they are examined in the same ultrasound.
Test yourself
Think of the answer, then tap the question to see it.
A 2-cm nodule is found with a low TSH. What is the next test, and why not FNA?
Scintigraphy: a low TSH suggests a hot (autonomous) nodule, which is almost never malignant and is not biopsied.
FNA reports a follicular neoplasm (Bethesda IV). Why can cytology not say whether it is cancer?
Follicular carcinoma is defined by invasion of the capsule or vessels, which can only be seen in the removed nodule, not in aspirated cells.
Which ultrasound features push a nodule towards biopsy?
Solid and hypoechoic, irregular margins, taller than wide, microcalcifications, extension outside the gland, or abnormal neck nodes.
A 1.2-cm nodule is solid, markedly hypoechoic, taller than wide and has microcalcifications. Why is FNA advised although it is small?
Its features add up to the highest ultrasound risk category (TI-RADS 5), where FNA is advised from about 1 cm; low-suspicion nodules are aspirated only when much larger.
FNA of a 2-cm nodule is Bethesda III (atypia of undetermined significance). What options can avoid an unnecessary operation?
Repeat FNA, or molecular testing of the aspirate: a negative test supports ultrasound follow-up, while BRAF V600E or a gene fusion points to cancer and surgery.
Elsewhere in DurgiPedia
Connections
See it in 3D1
The structures of Durgical's 3D anatomy where it is found.
Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.
Sources: Thyroid Nodule (StatPearls (NCBI Bookshelf), 2023); Thyroid Nodule Biopsy (StatPearls (NCBI Bookshelf), 2023).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
